In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines [PDF]
Paul La Rosée +9 more
openalex +1 more source
Study of Haploidentical Stem Cell Transplantation for Philadelphia/BCR-ABL Positive Acute Lymphoblstic Leukemia. [PDF]
Agrawal N +7 more
europepmc +1 more source
A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia [see comments] [PDF]
K Inokuchi +9 more
openalex +1 more source
Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study. [PDF]
Foulon S +7 more
europepmc +1 more source
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia. [PDF]
Luo Z +15 more
europepmc +1 more source
Evidence for a positive role of SHIP in the BCR-ABL–mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia [PDF]
Xiaoyan Jiang +8 more
openalex +1 more source
Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL–positive leukemic cells [PDF]
Ruriko Tanaka +14 more
openalex +1 more source

